An act relating to health insurance coverage for biomarker testing

The bill VT H0136 aims to ensure that health insurance plans cover biomarker testing, which is a type of medical test that helps identify specific characteristics of a patient's disease. This coverage would make it easier for patients to access important diagnostic tools that can guide their treatment options. The goal is to improve health outcomes by making these tests more affordable and accessible to those who need them.

Supporters of VT H0136 argue that the bill is a crucial step towards personalized medicine, allowing patients to receive tailored treatments based on their unique health profiles. They believe that covering biomarker testing will lead to better health outcomes and potentially lower overall healthcare costs by ensuring that patients receive the most effective treatments for their conditions.

Critics of VT H0136 may contend that mandating insurance coverage for biomarker testing could increase premiums for all policyholders. They might argue that while the intent is noble, the financial implications could strain the healthcare system and lead to higher costs for consumers who may not benefit from such tests.